Palliative care in patients with multiple sclerosis
Related Experiment Video
Updated: Sep 27, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
1Nurse Practitioner, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, The Mount Sinai Medical Center, New York, New York 10029, USA. aliza.ben-zacharia@mssm.edu
Abstract:
Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) and can be characterized by acute exacerbations or gradual worsening of neurological function and disability. The course of the disease is highly variable and unpredictable, however, there are short and long-term favorable and unfavorable predictive factors, which may provide some information about the future pattern of the disease. Palliative care in MS is directed at symptom management, psychosocial support, and rehabilitation. The goal in palliative care is to achieve a high quality of life. The disease modifying agents, interferon beta, Glatiramer acetate and Mitoxantrone are the mainstay of treatment in MS. Symptomatic relief and counseling of patients with MS have a strong impact on quality of life.
Related Concept Videos
Continuing Care
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Pancreatitis II: Collaborative Care
Assessment:
Peripheral Artery Disease IV: Nursing Management
Multiple Sclerosis l: Introduction

